Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: A study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte

Circulation

Volumn 108, Issue 11, 2003, Pages 1324-1328

  Zeymer, Uwe ^b   Uebis, Rainer ^c   Vogt, Albrecht ^c   Glunz, Hans Georg ^c   Vöhringer, Hans Friedrich ^a   Harmjanz, Dietrich ^c   Neuhaus, Karl Ludwig ^c  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c NONE

Author keywords

Angioplasty; Myocardial infarction; Prognosis; Survival

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; FIBRINOLYTIC AGENT; NITRATE; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY CIRCUMFLEX BRANCH; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERMANY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RIGHT CORONARY ARTERY; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE FREE SURVIVAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; MIDDLE AGED; SURVIVOR;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 0141431005     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000087605.09362.0E     Document Type: Article

References (22)

1. Fox KAA, Goodman SG, Klein W, et al. Management of acute coronary syndromes: variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events. Eur Heart J. 2002;23:1177-1189.
2. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: the Euro Heart Survey of acute coronary syndromes. Eur Heart J. 2002;23:1190-2001.
3. Pilote L, Miller DP, Califf RM, et al. Determinants of the use of angiography and revascularisation after thrombolysis for acute myocardial infarction. N Engl J Med. 1996;335:1198-1205.
4. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). Circulation. 2001;103:3019-3041.
5. Golia G, Marino P, Rametta F, et al. Reperfusion reduces left ventricular dilatation by preventing infarct expansion in the acute and chronic phases of myocardial infarction. Am Heart J. 1994;127:489-509.
6. Hirayama A, Adachi T, Asada S, et al. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without reduction of infarct size. Circulation. 1993;88:2565-2574.
7. White H, Cross DB, Elliott JM, et al. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation. 1994;89:61-67.
8. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis. Circulation. 1993;88:2426-2436.
9. Sadanandan S, Buller C, Menon V, et al. The late open artery hypothesis: a decade later. Am Heart J. 2001;142:411-421.
10. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation. 1998;98:2377-2382.
11. Vogt A, Tebbe U, Weber MA, Gottwik M. PTCA-Register der ALKK: Bericht 1998 und 1999. Z Kardiol. 2000;89:838-840.
12. The SWIFT Investigators. SWIFT trial of delayed elective intervention versus conservative treatment after thrombolysis with anistreplase in acute myocardial infarction: SWIFT (Should We Intervene Following Thrombolysis) Trial Study Group. BMJ. 1991;302:555-560.
13. Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317:581-588.
14. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the TIMI phase II trial. N Engl J Med. 1989;320:618-627.
15. Simoons ML, Arnold AER, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988;1:197-203.
16. Ellis SG, Mooney MR, George SB, et al for the TOPS Study Group. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenosis after thrombolytic treatment of myocardial infarction. Circulation. 1992;86:1400-1406.
17. Dalik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction. Circulation. 1998;98:2017-2023.
18. Madsen JK, Grande P, Saunamäki K, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation. 1997;96:748-755.
19. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J am Coll Cardiol. 1992;20:307-313.
20. Rankin JM, Spinelli JJ, Carere RG, et al. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med. 1999;341:1957-1965.
21. Morice C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
22. Stenestrand U, Wallentin L. Early revascularisafion and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet. 2002;359:1805-1811.